BioRestorative Therapies, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €345.48K +175.0% -€7.74M -13.8% -2,239.2% +49 pp -€7.00M +29.8% -2,026.0% +23 pp
    €125.61K +21.7% -€8.98M -42.2% -7,145.2% +79 pp -€5.39M +15.3% -4,293.0% +2.4 pp
    €103.21K +160.4% -€15.52M -39.8% -15,038.0% +500 pp -€4.68M +64.6% -4,533.0% +26 pp
    €39.63K -40.3% -€25.79M +144.3% -65,083.9% -490 pp -€2.84M +68.0% -7,172.3% -46 pp
    €66.34K -40.8% -€10.56M -31.6% -15,915.2% -21 pp -€1.69M -71.5% -2,551.0% +27 pp
    €112.00K +17.1% -€15.44M +43.2% -13,785.5% -25 pp -€5.93M +35.2% -5,294.7% -7.1 pp
    €95.63K +37.0% -€10.78M +32.5% -11,277.3% +3.8 pp -€4.39M +32.2% -4,587.2% +1.7 pp
    €69.79K +122.8% -€8.14M +9.4% -11,660.1% +120 pp -€3.32M -20.0% -4,753.3% +85 pp
    €31.32K -94.2% -€7.44M +9.0% -23,755.4% -220 pp -€4.15M +82.4% -13,241.4% -130 pp
    €541.84K +51.2% -€6.83M +41.8% -1,259.9% +0.83 pp -€2.27M -13.7% -419.6% +3.2 pp
    €358.40K +24,661.7% -€4.81M -2.8% -1,343.2% +3.4K pp -€2.64M +15.0% -735.5% +1.6K pp
    €1.45K -89.2% -€4.95M -12.0% -342,333.0% -3.0K pp -€2.29M +22.0% -158,407.4% -1.4K pp
    €13.43K +∞% -€5.63M +60.5% -41,931.6% -420 pp -€1.88M -21.9% -13,994.3% -140 pp
    €0.00 +NaN% -€3.51M +80.0% N/A -€2.41M +310.5% N/A
    €0.00 -€1.95M N/A -€586.23K N/A

    Notifications